The Decision Group Framework: a new way of looking at diagnostics

At the successful event on The Value of Diagnostics of June 5th 2012, The Decision Group Framework was launched. This decision framework for diagnostics will help organizations to asses the value of diagnostics. The framework and methodology received very positive replies from the audience:

  • The event was very usefull and inspiring. It gave me a new vision on how to interpret costs and value. – Medical specialist
  • The Decision Framework is innovative and can result in product improvement. The Value of Diagnostics is the ‘new thinking’  – Director of Life Sciences company
  • The Decision Group succeeded to open a new discussion on diagnostics, via a differen point of view and a practical approach’  – Head Clinical Chemistry

A large variety of stakeholder groups were present at the event. A sample of the companies and organisations represented:

Borstkankervereniging Nederland IKNL
Check-Points B.V.  Isala Klinieken
Citeq Health Products Ned. Ver. voor Radiologie
De Friesland Zorgverzekeraar Nucletron
Diaconessenhuis Meppel NVOG
Distrilab BV Philips Healthcare Benelux
E-nose Radboud University Nijmege MC
Erasmus MC Roche Diagnostics Nederland
Flevoziekenhuis Saltro 
Forbion Capital Partners Saxenburgh groep
GE Healthcare St Lucas Andreas Ziekenhuis
Glaxo Smith Kline Virtual Proteins BV
Haga Teaching Hospital Vu University Medical Center
Hycult Biotech  


During the discussion it became clear that this new approach brings high added value for the different stakeholders.  Actions to learn more:

See also

– The Decision Group Healthcare Consulting
– The Decision Group Life Sciences Consulting

Executive Education Programs Healthcare by affiliate The Decision Institute: 
Clinical Management Workshop Series
Masterclasses Value Based Health Care
Strategy & Goverancence Excellence Series
Masterclass Healthcare ‘New&Improved’

Comments are closed.